Descrizione business
Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. The Company is committed to having a positive impact on patients’ lives by delivering high-quality, safe and effective treatments designed to address debilitating retina diseases including all stages of age-related macular degeneration.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Glenn P. Sblendorio |
| Consiglio di amministrazione |
| David F. Carroll, Keith Westby, Pravin U. Dugel |
| Consiglio di sorveglianza |
| Adrienne L. Graves, Axel Bolte, Calvin Roberts, Glenn P. Sblendorio, Jane Pritchett Henderson, Mark S. Blumenkranz |
Dati aziendali
| Name: |
Iveric Bio Inc. |
| Indirizzo: |
Five Penn Plaza, Suite 2372,New York, NY 10001, USA |
| Telefono: |
+1-212-845-8200 |
| Fax: |
- |
| E-mail: |
info@ivericbio.com
|
| Internet: |
https://ivericbio.com/ |
| Industria: |
Biotechnology |
| Settore: |
Biotechnology |
| Sub settore: |
Biotechnology |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
- |
| Data dell'IPO: |
16/12/2016 |
